奇纳卡塞特可以逆转家族性低性高血症1型的短QT间隔
Thomas Cuny1, Pauline Romanet2, Michelle Goldsworthy3
1Aix Marseille University, APHM, Marseille Medical Genetics, Inserm U1251, Hôpital de la Conception, Service d'Endocrinologie, Marseille, France.
The Journal of clinical endocrinology and metabolism
|August 21, 2023
概括
有较短QT间隔的1型家族低血性高血症 (FHH-1) 患者可能会从cinacalcet中受益. 在一项针对三个家庭成员的研究中,这种治疗可以纠正QT间隔并使水平正常化.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
背景情况:
- 家族性低血性高血症1型 (FHH-1) 是由CASR基因突变引起的自体主导性疾病,通常呈现出轻度高血症.
- 据报道,FHH-1与短QT间隔之间存在一种新的关联,这是一种导致心律不整的条件.
研究的目的:
- 为了研究三个FHH-1患者的QT间隔较短.
- 评估cinacalcet,一种仿剂,在纠正短QT间隔和异常感受受体 (CaSR) 灵敏度方面的疗效.
主要方法:
- 在CASR基因测序中,发现了p.Ile555Thr变异.
- 在HEK293细胞中的功能研究评估了CaSR变体的功能和cinacalcet的影响.
- 一个涉及注射30毫克的cinacalcet和监测血清,酸盐,甲状腺激素和心电图参数超过8小时的试验.
主要成果:
- 鉴定的CaSR变种 (p.Ile555Thr) 显示功能丧失的特征,这些特征被cinacalcet改善.
- 奇纳卡塞特在2小时内显著降低了副甲状腺激素水平,并在8小时内使血清和酸盐水平正常化.
- 简短的QT间隔被cinacalcet纠正,并在治疗3个月期间保持正常.
结论:
- 对于FHH-1患者,应对短的QT间隔进行查.
- 一个cinacalcet挑战测试可以识别可能从这种治疗干预中受益的患者.
- 这项研究突出了FHH-1患者心脏并发症的潜在治疗策略.
更多相关视频
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10.2K
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.0K
相关概念视频
00:51Synthesis and Functions of Calcitonin
2.0K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
2.0K
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
13
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
13
01:28Urinary Tract Calculi I: Introduction
16
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
16
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
875
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
875
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
11
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
11
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
634
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
634